ROLE OF SDF-1 AND CELECOXIB IN INCREASING QUANTITY OF NEURAL STEM CELL IN THE LESION ZONE AND OUTCOME OF SPONTANEOUS INTRACEREBRAL HEMORRHAGE
Keywords:
Key words, neuroinflammation, cyclooxygenase-2, Bederson scaleAbstract
Objective: We studied the effect of stromal derived factor-1 (SDF-1) and celecoxib for increasing the amount of neural stem cells in the lesion zone and clinical outcomes of spontaneous intracerebral hemorrhage.
Methods: Twenty-eight rats, strain Wistar, divided into four groups: control, treated with celecoxib, SDF-1, and the combination of celecoxib+SDF-1. The neural stem cells identified by immunohistochemistry procedures with Nestin as primary antibodies and the levels of proliferation were assessed by Ki-67 as primary antibodies. The clinical outcomes were examined by Bederson scale.
Results: This study revealed the combination treatment group had the highest histoscores of Nestin and highest of Ki-67 histoscores for SDF-1 group. The amount of neural stem cells in the lesion zone of treatments groups was higher than controls (p<0.005), but similar between treated groups (P>0.05). The proliferation levels were higher in SDF-1 group (P<0.05), and the clinical outcomes back to normal were highest in combination therapeutic groups, even though not different when compared to another group (p>0.05).
Conclusion: The results suggest celecoxib, SDF-1, and the combination of celecoxib+SDF-1 can increase neural stem cells in spontaneous intracerebral hemorrhage, and SDF-1 increased proliferation levels. The clinical outcomes were not significantly different between rats, regardless of the fact that almost all of rats in the combination group were back to normal.
Keywords: Neuroinflammation, Cyclooxygenase-2, Bederson Scale
Downloads
References
Greenberg MS. Handbook of neurosurgery. 4th ed. Florida: Greenberg Graphics; 2008.
Caplan LR. Caplan’stroke: a clinical approach. 4th ed. Philadelphia: Saunders Elsevier; 2009.
Health Department of Indonesian Republic. Health profile of Indonesia 2008. Jakarta; 2009.
Endres M, Dirnagl U, Moskowitz MA. The ischemic cascade and mediators of ischemic injury. In: Fisher M. editor. Handbook of clinical neurology. Vol. 92. Stroke part I: basic and epidemiological aspects. Edinburgh, Elsevier; 2009. p. 31-41.
Qureshi AI, Tuhrim S, Broderick JP, Batjer H, Hondo H, Hanley DF, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-60.
Yamada Y, Metoki N, Yoshida H, Satoh K, Kato K, Hibino T, et al. Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. Stroke 2008;39:2211-8.
Sturm JW, Mackay MT, Thrift AG. Stroke among women, ethnic groups, young adults, and children. In: Fisher M. editor. Handbook of clinical neurology. Vol. 92. Stroke part I: basic and epidemiological aspects. Edinburgh, Elsevier; 2009. p. 337-53.
Olsen TS. Stroke recurrence and prognoses after stroke. In: Fisher M. editor. Handbook of clinical neurology. Vol. 92. Stroke part I: basic and epidemiological aspects. Edinburgh, Elsevier; 2009. p. 407-21.
Sinurat R. Outcomes of spontaneous intracerebral hemorrhagic after surgery. Proceedings of 9thAsian Congress of Neurological Surgeons; Istanbul, Turkey; 2012.
Caplan LR. Caplan’stroke: a clinical approach. 4ed. Philadelphia: Saunders Elsevier; 2009.
Mengzhou X, Bigio D. Intracortical hemorrhage injury in rats: the relationship between blood fraction and cell death. Stroke 2000;31:1721-7.
Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010;92:463-77.
Wang J, Dore S. Heme oxygease-1 exacerbates early brain injury after intracerebral haemorrhage. Brain 2007;130:1643-52.
Shinohara Y. Hemorrhagic stroke syndromes: clinical manifestations of intracerebral and subarachnoid hemorrhage. In: Fisher M. editor. Handbook of clinical neurology. Vol. 93. Stroke part II: manifestations and pathogenesis. Edinburgh, Elsevier; 2009. p. 577-94.
Loftspring MC, Hansen C, Clark JF. A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system. Med Hypotheses 2010;74:63-6.
Callaghan GO, Kelly J, Shanahan F, Houston A. Prostaglandin E2 stimulates fas ligand expression via the EP1 receptor in colon cancer cells. Br J Cancer 2008;99:502-12.
Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl d-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000;293:417-25.
Chu K, Jeong SW, Han SY, Lee ST, Kim M, Roh JK. Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 2004;24:926-33.
Otero L, Zurita M, Bonilla C, Rico MA, Aguayo C, Rodriquez A, et al. Endogenous neurogenesis after intracerebral hemorrhage. Histol Histopathol 2012;27:1-13.
Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol 2005;18:59-64.
Lindvall O, Kokaia Z. Recovery and rehabilitation in stroke. Stroke 2004;35:2691-4.
Shen J, Xie L, Mao XO, Zhou Y, Zhan R, Greenberg DA, et al. Neurogenesis after primary intracerebral hemorrhage in adult human brain. J Cereb Blood Flow Metab 2008;28:1460-8.
MacLellan CL, Silasi G, Auriat AM, Colbourne F. Rodent models of intracerebral hemorrhage. Stroke 2010;41(10 Suppl):S95-8.
MacLellan CL, Silasi G, Poon CC, Edmunson CL, Buist R, Peeling J. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab 2008;28:516-25.
Kokovay E, Goderie S, Wang Y, Lotz S, Lin G, Sun Y, et al. Adult SVZ lineage cells home and to leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cells 2010;7:163-73.
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17:472-6.
Du K, Peng Y, Zhang L, Liang A, Huang D. Expression of the stem cell marker nestin in pre/hypertrophic chondrocytes in osteochondroma. J Int Med Res 2011;39:348-57.
Kee N, Sivalingam S, Boonstra R, Wojtowicz JM. The utility of Ki-67and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 2002;115:97-105.
Bulwinkel J, Luhr BB, Ludeman A, Wohlenberg C, Gerdes J, scholzen T. Ki-67 protein ia associated with ribosomal RNA transcription in quiescent and proliferating cells. J Cell Physiol 2006;3:624-35.
Zhang RL, Zhang ZG, Zhang L, Chopp M. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 2001;105:33-41.
Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K. JNK phosphorylates paxillin and regulates cell migration. Nature 2003;424:219-22.
Arimitsu N, Shimizu J, Fujiwara N, Takai K, Takada E, Kono T, et al. Role of SDF1/CXCR4 interaction in experimental hemiplegic models with neural cell transplantation. Int J Mol Sci 2012;13:2636-49.
Mori T, Doi R, Koizumi M, Toyoda E, Ito D, Kami K, et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. Mol Cancer Ther 2004;3:29-36.
Kucia M, Reca R, Miekus K, Wanzeck, Wojakowski W, Wieczorek AJ, et al. Trafficking of normal stem cells involve silimar mechanisms: pivotal role of the SDF-1—CXCR4 axis. Stem Cells 2005;23:879-94.
Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al. Directed migration of neural stem cells to sites of cns injury by the stromal-cell-derived factor 1/cxc chemokine receptor pathway. Proc Natl Acad Sci 2004;101:18117-22.
Buylla A, Verdugo G, Tramontin AD. Unified hypothesis on the lineage of neural stem cells. Neuroscience 2001;2:287-93.
Kornblum HI. Stem cells and stroke recovery: an introduction. Stroke 2007;38:810-6.
Maslov YA, Barone TA, Plunkett RJ, Pruitt SC. Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice. J Neurosci 2004;24:1726-33.
Sommer L, Rao M. Neural stem cells and regulation of cell number. Prog Neurobiol 2002;66:1-18.
Yang S, Song S, Hua Y, Nakamura T, Keep RF, Xi G. Effects of thrombin on neurogenesis after intracerebral hemorrhage. Stroke 2008;39:2079-84.
Nogawa S, Zhang F, Ross M, Iaddecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997;17:2746-55.
Sinn DI, Lee ST, Chu K, Jung KH, Song EC, Kim JM, et al. Combined neuroprotective effects of celecoxib and memantine in experimental intracerebral hemorrhage. Neurosci Lett 007;411:238-42.
Gong C, Ennis SR, Hoff JT, Keep RF. Inducible cyclooxygenase-2 expression after experimental intracerebral hemorrhage. Brain Res 2001;901:38-46.
Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA. Prostaglandin E2 EP1 receptors: downstream effectors of cox-2 neurotoxicity. Nat Med 2006;12:225-9.
Zhou P, Qian L, Chou T, Ladecola C. Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway. Neurobiol Dis 2008;29:543-51.
Andreasson K. Prostaglandin is signaling in cerebral ischemia. Br J Pharmacol 2010;160:844-6.
Takahashi T, Nowakowski RS, Caviness Jr VS. Mode of cell proliferation in the developing mouse neocortex. Proc Natl Acad Sci 1994;91:375-9.